SIAM Conference on Computational Geometric Design (GD23)

Registration Now Open!

2023-03-08

(Press-News.org) The 2023 SIAM Conference on Computational Geometric Design, organized by the SIAM Activity Group on Geometric Design, is part of the International Geometry Summit bringing together the Symposium on Physical and Solid Modeling 2023, Shape Modeling International 2023, EG Symposium on Geometry Processing 2023, and Geometric Modeling and Processing 2023.

The 2023 SIAM Conference on Computational Geometric Design seeks high quality, original research contributions that strive to advance all aspects of applied algebraic/differential/computational/discrete geometry and topology, and their industrial applications in design, analysis, and manufacturing as well as in biomedical, geophysical, digital entertainment, and other areas.

After the conference, GD23 will include a track for submission of technical papers. All papers will be rigorously peer-reviewed by members of the GD23 international program committee and will be published as a journal special issue in Computer Aided Geometric Design (Elsevier).

The Geometry Summit will feature a poster session. To facilitate participation, limited travel awards for students and early career academics are available.

END

ELSE PRESS RELEASES FROM THIS DATE:

Study associates long COVID with physical inactivity

2023-03-08

The link between symptoms of COVID-19 and physical inactivity is increasingly evident. An article recently published in the journal Scientific Reports by researchers at the University of São Paulo (USP) in Brazil describes a study in which COVID-19 survivors with at least one persistent symptom of the disease were 57% more likely to be sedentary, and the presence of five or more post-acute sequelae of infection by SARS-CoV-2 increased the odds of physical inactivity by 138%. “Although this was a cross-sectional study, the findings underscore the importance of discussing and encouraging physical activity at all times, including during the pandemic,” ...

Scientists uncover the unexpected identity of mezcal worms

2023-03-08

Mezcal is a distilled alcohol made from the boiled and fermented sap of agave plants. Most mezcal beverages — including all brands of tequila — are sold as pure distillates, but a few have an added stowaway bottled inside: worms. Called gusanos de maguey (Spanish for agave worms), these odd organic chasers aren’t actually worms, but instead a type of insect larva, and their addition to mezcal is a recent one. Mezcal production has a storied history, dating back to the first Spanish inhabitants of Mexico, but larvae were only added to the drink in ...

AERA announces 2023 fellows

2023-03-08

WASHINGTON, March 8, 2023—The American Educational Research Association (AERA) has announced the selection of 24 exemplary scholars as 2023 AERA Fellows. The AERA Fellows Program honors scholars for their exceptional contributions to, and excellence in, education research. Nominated by their peers, the 2023 Fellows were selected by the Fellows Committee and approved by the AERA Council, the association’s elected governing body. They will be inducted during a ceremony at the 2023 Annual Meeting in Chicago on April 14. They join a total of 714 AERA Fellows. “AERA Fellows demonstrate the highest standards ...

A better way to produce fertilizers

2023-03-08

Fertilizers are one of the main reasons that we are able to grow enough crops to feed the almost 8 billion humans living on Earth. Modern agriculture depends largely on nitrogen-based fertilizers, which significantly increase the yield of crops. Unfortunately, a great portion of these fertilizers are produced at an industrial level, consuming fossil fuel energy and causing nitrogen pollution. One attractive way to minimize our use of industrially produced fertilizers is to harness the power of nitrogenases. ...

University of Cincinnati study finds little federal funding for incarceration-related research

2023-03-08

Research from the University of Cincinnati finds a lack of federal funding for incarceration-related research. The study looked at data from the Department of Justice, National Institutes of Health (NIH) and National Science Foundation, some of which dated back to 1985. The study was published recently in the journal JAMA Network Open. “We have very little evidence-based research on how and when to intervene with children and families when someone is removed from the home due to incarceration, especially on how to ...

How nanoplastics can influence metabolism

2023-03-08

PET, the plastic used to make bottles, for example, is ubiquitous in our natural environment. In a joint study, scientists from Leipzig University and the Helmholtz Centre for Environmental Research (UFZ) investigated the negative effects that tiny plastic PET particles can have on the metabolism and development of an organism. Their findings have now been published in the journal Scientific Reports. The increasing use of plastic is threatening ecosystems around the world. One of the big concerns is the presence of plastics in the form of small particles, also called microplastics and nanoplastics. ...

Virginia Tech researchers study PTSD effects on bystanders

2023-03-08

The traditional line of thought is that post-traumatic stress disorder (PTSD) is caused by directly experiencing the traumatic event. However, about 10 percent of diagnosed PTSD occurs when people witness these events versus experiencing it directly themselves. Little is known about these cases of PTSD, but that’s something that Tim Jarome, an associate professor in the College of Agriculture and Life Sciences School of Animal Sciences, is aiming to change with a $430,000 grant from the National Institute ...

New pain medications are still widely inaccessible to individuals living with sickle cell disease

2023-03-08

(WASHINGTON, March 8, 2023) – Sickle cell disease (SCD), a rare chronic, progressive, life-threatening, inherited blood disorder, often affects individuals with chronic pain that can be debilitating to their quality of life. Yet less than 4% of people living with SCD who experience chronic pain episodes have prescriptions for newer FDA-approved pain-relieving drugs, including l-glutamine, voxelotor, and crizanlizumab, according to a new study published in Blood Advances. Further, researchers found that less than a third of patients with pain episodes have prescriptions for hydroxyurea, ...

Two-pronged immunotherapy eliminates metastatic breast cancer in mice

2023-03-08

Metastatic breast cancer has no cure and has proven stubbornly resistant to one of the most innovative and promising new cancer treatments: immunotherapy. Now, researchers at Washington University School of Medicine in St. Louis have identified a way to treat the area surrounding breast tumors that have spread to bone so that such tumors become vulnerable to attack by the body’s immune system. When the researchers boosted the activity of certain immune cells, called T cells and macrophages, these immune cells worked together to clear metastatic breast tumors that had spread to the bones of mice, and continued to eliminate tumor cells ...

Researchers take a step towards turning interactions that normally ruin quantum information into a way of protecting it

2023-03-08

Researchers have found a way to predict the behavior of many-body quantum systems coupled to their environment. The work represents a way to protect quantum information in quantum devices, which is crucial for real-world applications of quantum technology. In a study published in Physical Review Letters, researchers at Aalto University in Finland and IAS Tsinghua University in China report a new way to predict how quantum systems, such as groups of particles, behave when they are connected to the external environment. ...

LAST 30 PRESS RELEASES:

New antibody-drug conjugate shows promising efficacy in EGFR-mutated NSCLC patients

Iza-Bren in combination with osimertinib shows 100% response rate in EGFR-mutated NSCLC, phase II study finds

COMPEL study shows continuing osimertinib treatment through progression with the addition of chemotherapy improves progression-free survival in EGFR-mutated NSCLC